Results 91 to 100 of about 113,966 (168)

Efficacy and safety of efruxifermin for patients with NASH/MASH: an updated systematic review and meta-analysis. [PDF]

open access: yesFront Pharmacol
Xiao YJ   +7 more
europepmc   +1 more source

The metabolic vulnerability index predicts outcomes in patients with metabolic dysfunction associated steatotic liver disease. [PDF]

open access: yesNat Commun
Siddiqui MS   +17 more
europepmc   +1 more source

Fibrotic NASH Index (FNI) Is Associated with Long-Term Mortality in Individuals with Type 2 Diabetes and MASLD. [PDF]

open access: yesLiver Int
Barchetta I   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy